Models to study disease progression in Lung cancer patient
We will also like to evaluate effectiveness of clinical factors in lung cancer and validate its effectiveness in our local cancer centers cohorts.
1) Evaluate radiological characteristics along with quantitative imaging metrics on pre-diagnostic X-ray images as markers for disease progression.
2) Evaluate effectiveness of pathological, genomic markers along with available imaging and clinical information to prognosticate disease progression
Gage, Kenneth L. <Kenneth.Gage@moffitt.org>
Choi, Jung W. <Jung.Choi@moffitt.org>